Pisgah Labs to invest $55M in North Carolina facility

Last edition

Pisgah Labs to invest $55M in North Carolina facility

Pisgah Laboratories, an API maker, will invest $55 million to upgrade its manufacturing facility in Pisgah Forest, North Carolina, to include sterile injectables and liquid filling operations. The company is a subsidiary of India-based Ipca Laboratories.

The project also includes the addition of a new pilot manufacturing facility, quality control lab, warehousing and microbiological labs. Additional details about the project, such as a completion date, weren’t disclosed.

Read more on:
IPCA Pharma Facilities Pharma Manufacturing

More news about: industrial talks | Published by Sudeep Soparkar | August - 12 - 2022 | 410

Last news about this category

Aprotec Offers its Customers Turnkey Systems for Customised Applications

Cardiotrack Secures USD 2 Million in Pre-Series A Funding

Lupin Receives Approval from US FDA for Varenicline Tablets

Brenntag Specialties and Zeochem Expand Business Collaboration for Pharma EMEA

Cromatic Closes USD 5.3 Million in Oversubscribed Seed Round to Modernize Life Science R&D Outsourcing

Piramal Pharma Gets EIR from US FDA for Bethlehem Plant

Allcargo Supply Chain Launches State-Of-The Art Chemical Warehouse at Navi Mumbai

Great Place to Work Institute Certifies Thermo Fisher Scientific for Fifth Consecutive Year

Pharma Pro&Pack Expo, analytica Anacon India and India Lab Expo to Showcase Innovations in Pharma Processing Equipment and Laboratory Technology

Glenmark Pharmaceuticals in Process of Recalling 1,200 Bottles of Subpotent Hypertension Drug in USA

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy